The risk prediction for developing lifestyle diseases through non-invasive tests

The risk prediction for developing lifestyle diseases through non-invasive tests - The risk prediction for developing lifestyle diseases through non-invasive tests

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057709

Enrollment

800

Registered

2025-04-25

Start date

2025-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Male and female employees of the Glico Group aged of 18-65 years at the date of informed consent

Exclusion criteria

Exclusion criteria: ?Subjects who have an implantable cardioverter defibrillator (ICD) or a medical equipment necessary for life support ?Subject who is pregnant or under lactation, or who is expected to be pregnant during the study ?Subjects who have aneurism ?Subjects who have deep vein thrombosis of lower limb

Design outcomes

Primary

Measure	Time frame
The accuracy of the risk prediction model for developing lifestyle diseases	—

Secondary

Measure	Time frame
The effectiveness of accelerated plethysmography and autonomic nerves in the risk prediction model for developing lifestyle diseases	—

Countries

Japan

Contacts

Public ContactRisa Matsui

Ezaki Glico Co., Ltd. R&D Laboratory

risa.matsui@glico.com080-2545-5759

Outcome results